Clinical Trial

Use of Methazolamide to Lower Intraocular Pressure

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the effect of methazolamide, 25 mg or 50 mg tablets once a day for a week than twice a day for a week, on lowering intraocular pressure and the safety of methazolamide.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-08-09; most recent amendment 2025-05-07.
Status change: Active, Not Recruiting → Completed 2025-05-07
Status change: Recruiting → Active, Not Recruiting 2024-02-05
Status change: Not Yet Recruiting → Recruiting 2022-12-19
Trial Details
NCT Number NCT05498103
Lead Sponsor University of Colorado, Denver
Conditions Glaucoma, Open-Angle
Enrollment 30 participants
Start Date 2023-02-17
Primary Completion 2023-09-14 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2024-02-06